| van Dessel, Vincent (Euronext 201511 CEO of Euronext Brussels) |
Chief Executive Officer (CEO) |
Euronext (Group) |
Belgium |
| van Deventer, Sander (Forbion 201204 General Partner) |
General Partner (venture partner) |
Forbion Capital Partners (NL) |
Netherlands |
| van Duijnhoven, Henk (Danaher 201409 SVP Dental Segment) |
President/Director/Head Business Group/Unit/Division |
Danaher (Group) |
United States (USA) |
| van Gool, Alain (Univ Nijmegen 201904 Prof + Head of CoE for Translational Omics) |
Professor |
University of Nijmegen (Radboud University) |
Netherlands |
| van Gorp, Jasper (Gilde Investment 201708 Managing Partner at Gilde Healthcare) |
Managing Partner |
Gilde Investment (Group) |
Netherlands |
| van Hagen, Paul (Xeltis 201602– CFO before Prosensa + Crucell + Ernst & Young) |
Chief Financial Officer (CFO) |
Xeltis (Group) |
Switzerland |
| van Hall, Andre (BioCampus Cologne 201307– Prokurist before BioMedizinZentrum Dortmund) |
n. a. |
BioCampus Cologne Management GmbH |
Germany |
| Van Hauwermeiren, Tim (Argen-X 201101 CEO before Ablynx BusDev Manager before P&G) |
Chief Executive Officer (CEO) |
Argenx (Argen-X) (Group) |
Netherlands |
| van Heekeren, Robbert (Kiadis Pharma 2008–201808 CFO LEFT 8/18) |
Chief Financial Officer (CFO) |
Kiadis (Group) |
Netherlands |
| van Hoeven, Kees (Netherlands (govt) 201405 RVO) |
Administrative Officer (personnel) |
Netherlands (govt) |
Netherlands |
| van Houten, François Adrianus (Frans) (Philips 201104– designated CEO before since 1986 at Philips) |
Chief Executive Officer (CEO) |
Philips (Group) |
Netherlands |
| van Husen, Georg (Boehringer Ingelheim 201804 SVP Therapeutic Area CardioMetabolism) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Germany |
| van Koppen, Chris J. (ElexoPharm 201201– Head of Research before Merck Sharp & Dohme NL) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
ElexoPharm GmbH |
Germany |
| van Lent, Horst-Dieter (Omnibal 200906 Head Purchasing) |
Business Manager |
Omnilab (DE) (Group) |
Germany |
| Van Naarden, Jacob (Loxo Oncology 201711 CBO) |
Chief Business Officer (CBO) |
Eli Lilly (Group) |
United States (USA) |
| van Pelt, Eva (Eppendorf 201912– Co-CEO joined 201710 before Leica Microsystems + Hitachi + Siemens) |
Chief Executive Officer (CEO) |
Eppendorf (Group) |
Germany |
| Van Rie, Jeroen (Bayer 201706 Crop Efficiency Trait Research expert) |
n. a. |
Bayer (Group) |
Germany |
| van Tilburg, Maurice (Euronext 201511 CEO of Euronext Amsterdam) |
Chief Executive Officer (CEO) |
Euronext (Group) |
Netherlands |
| van Tulder, Arnoud (Cryo-Save 201105 CEO) |
Chief Executive Officer (CEO) |
Esperite (Group) |
Netherlands |
| van Tunen, Arjen (Keygene 200601 CEO) |
Chief Executive Officer (CEO) |
KeyGene N.V. |
Netherlands |
| van Winsen, Joris (Labfolder 2015– Managing Director CFO) |
Managing Director |
Labforward (Group) |
Germany |
| van Zyl, Charl (Jado Technologies 200709–200901 CEO left 1/09 before Novartis before Lilly) |
Chief Executive Officer (CEO) |
Jado Technologies GmbH |
Germany |
| Vandenhirtz, Dirk (LemnaTec 201104 Managing Director) |
Managing Director |
Nynomic (Group) |
Germany |
| Vanderhaegen, Frederic (Tecan 201202 Head Life Sciences Business) |
President/Director/Head Business Group/Unit/Division |
Tecan (Group) |
Switzerland |
| Vangeel, Frankie (VWR 201602 Managing Director at VWR International GmbH) |
Managing Director |
Avantor (Group) |
Germany |
| Vanhoyland, Geert (Bruker 201606 Global Product Manager Materials Research at Bruker AXS) |
Product Manager (personnel) |
Bruker Corporation (Group) |
Germany |
| Vann, Christopher (Autolus 201707– COO before Roche) |
Chief Operating Officer (COO) |
Autolus Therapeutics plc (Nasdaq: AUTL) |
United Kingdom (GB) |
| VanOort, Douglas (NeoGenomics 201703 CEO) |
n. a. |
NeoGenomics Inc. (Nasdaq: NEO) |
United States (USA) |
| Varma, Suneet (Pfizer 201712 Global President of Pfizer APAC, Greater China + Global Brands) |
President/Director/Head Business Group/Unit/Division |
Pfizer (Group) |
United States (USA) |
| Varney, Michael D. (Roche 201501 promoted Head of gRED before Genentech 200610 VP Small Molecule Drug Discovery) |
President/Director/Head Business Group/Unit/Division |
Roche (Group) |
United States (USA) |
| Vasella, Daniel (Novartis CEO 199612–201001 after 1/10 continues as Chairman) |
Board member, non-executive |
Novartis (Group) |
Switzerland |
| Vater, Wulf (Bayer 199710) |
n. a. |
Bayer (Group) |
Germany |
| Vaussy, Hugues (Eurofins 201707 Finance Director) |
Chief Financial Officer (CFO) |
Eurofins (Group) |
Luxembourg |
| Vazirani, Suresh (Erba Diagnostics Mannheim 201509 Managing Director) |
Managing Director |
Erba Diagnostics Mannheim (Group) |
Germany |
| Végh, Mátyás (Creoptix 201210–201912 Managing Partner before Genetics Company LEFT 1/20) |
Managing Partner |
Creoptix AG |
Switzerland |
| Veitch, David (Basilea 201804– CEO before CCO since 201408 before Savient + BMS) |
Chief Executive Officer (CEO) |
Basilea (Group) |
Switzerland |
| Veitschegger, Andrea (ÖGMBT 201105 Managing Director) |
Managing Director |
Österreichische Gesellschaft für Molekulare Biowissenschaften und Biotechnologie (ÖGMBT) |
Austria |
| Velasco, Martin (AC Immune 201401 Board Chairman) |
Board member, non-executive |
AC Immune S.A. (Nasdaq: ACIU) |
Switzerland |
| Velden, Torsten (Bayer 201208 Bayer CropScience Country Head for Vietnam) |
Regional manager |
Bayer (Group) |
Germany |
| Veldman, Robert (Bipharma 201204 CEO) |
Chief Executive Officer (CEO) |
Bipharma B.V. |
Netherlands |
| Velling, Johannes (Germany (govt) 201502 Head Division KfW, Seed + Start-up Financing) |
Administrative Officer (personnel) |
Germany (govt) |
Germany |
| Velten, Jürgen |
n. a. |
Baden-Württemberg (govt region) |
Germany |
| Venter, J. Craig |
n. a. |
VENTER Group [Craig Venter / Claire Fraser] (Group) |
United States (USA) |
| Ventur, Yvonne (Orexo 201207 Kibion Country Manager Germany) |
Regional manager |
Mayoly Spindler (Group) |
Germany |
| Venturi, Miro (Roche 201101 Senior Biomarker + Experimental Medicine Leader) |
Research & Development Manager |
Roche (Group) |
Switzerland |
| Verbraeken, Paul (Evolva 201105 Investor Relations Manager) |
Public Relations Manager / Investor Relations Manager |
Evolva (Group) |
Switzerland |
| Verghese, Jacob (Trophic Communications 201811) |
Public Relations Manager / Investor Relations Manager |
Trophic Communications GmbH |
Germany |
| Verhaeghe, Peter (Benaruca 200910) |
Investment Manager |
Benaruca (LU) (family offfice of Rudi Pauwels) |
Luxembourg |
| Verhaert, Raymond (ProteoNic 201105 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
ProteoNic Biotechnology B.V. |
Netherlands |
| Verhey, Janko F. (MVIP ImagingProducts 200912 Managing Director + Co-Founder) |
Managing Director |
MVIP (Group) |
Germany |
| Verhey, Martina (MVIP ImagingProducts 200912 Managing Director + Co-Founder) |
Managing Director |
MVIP (Group) |
Germany |
| Verheyen, Frank (Techniker Krankenkasse 200901– Director of WINEG) |
President/Director/Head Business Group/Unit/Division |
Techniker Krankenkasse (Group) |
Germany |
| Verhoef, Clarence (Varex Imaging 201701– CFO) |
Chief Financial Officer (CFO) |
Varex Imaging (Group) |
United States (USA) |
| Verjee, Rehan (Merck (DE) 201809– President EMD Serono before EVP Chief Marketing + Strategy Officer joined 2004) |
President/Director/Head Business Group/Unit/Division |
Merck (DE) (Group) |
United States (USA) |
| Verland, Sten (Sunstone Capital 200705– Partner Life Science Ventures) |
Partner (venture partner) |
Sunstone Capital A/S |
Denmark |
| Vermeylen, Krisja (Novo Group 201704 SPV Corp People + Organisation joined before 1997 before Pharmacia) |
President/Director/Head Business Group/Unit/Division |
Novo Group (Group) |
Denmark |
| Veromaa, Timo (BioTie 1998– VP RnD promoted CEO 5/05 before Schering Oy before Collagen Corp) |
Chief Executive Officer (CEO) |
Acorda Therapeutics (Group) |
Finland |
| Vertes, Akos (George Washington Univ 2000– Prof before Associate Prof since 1991) |
Professor |
George Washington University |
United States (USA) |
| Ververken, Cedric (Confo Therapeutics 201610– CEO before Ablynx) |
Chief Executive Officer (CEO) |
Confo Therapeutics N.V. |
Belgium |
| Verwiel, Frank (ObsEva 2016– Board Director before CEO of Aptalis Pharma) |
n. a. |
ObsEva (Group) |
Switzerland |
| Verzetnitsch, Ulrike (Apceth 201612 CTO at Apceth Biopharma GmbH) |
Chief Technology/Technical Officer (CTO) |
Hitachi (Group) |
Germany |
| Vessey, Rupert (Celgene 201701 EVP + President RnD before Merck & Co 200906 VP Merck Research Laboratories) |
President/Director/Head Business Group/Unit/Division |
Celgene (Group) |
United States (USA) |
| Vetter, Dirk (Perora GmbH 201306– Managing Director + Co-founder) |
Managing Director |
Perora GmbH |
Germany |
| Vetter, Udo J. (UV-Cap 201702 Founder + Managing Director) |
Managing Director |
|
|
| Veugelers, Mark (VIB 201408 Tech Watch team) |
IP Manager |
VIB (Flanders Interuniversity Institute for Biotechnology) |
Belgium |
| Vianna, Eduardo (NovaGo Therapeutics201903 CEO) |
Chief Executive Officer (CEO) |
NovaGo Therapeutics AG |
Switzerland |
| Vicari, Alain (Calypso Biotech 201703 CEO) |
Chief Executive Officer (CEO) |
Calypso Biotech (Group) |
Switzerland |
| Viehbacher, Christopher A. (Chris) (Bertarelli Group 201510 Managin Partner Gurnet Point Capital before Sanofi + GSK) |
Managing Partner |
BERTARELLI Group (family of Ernesto Bertarelli) |
United Kingdom (GB) |
| Vielsack, Claus (Stratec 201402– Executive Management Board Member for Product Development joined 1998) |
Board member, executive |
Stratec (Group) |
Germany |
| Viëtor, Henk (Oncodrone 201508 CEO before Skyline Diagnostics CEO) |
Chief Executive Officer (CEO) |
SkylineDx B.V. |
Netherlands |
| Vigneault, Francois (AbVitro 201410 CSO + Co-founder) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Celgene (Group) |
United States (USA) |
| Vignon, Guillaume (BeiGene 201810 SVP Business Development at BeiGene Switzerland GmbH) |
Business Development Manager / Strategy Manager |
BeiGene (Group) |
Switzerland |
| Vile, Hollie (Optimum Strategic Communicatons 201710 before Hume Brophy + M:Communications) |
Public Relations Manager / Investor Relations Manager |
Optimum Strategic Communications |
United Kingdom (GB) |
| Villain-Guillot, Philippe (Nosopharm 201703 President) |
Chief Executive Officer (CEO) |
Nosopharm S.A.S. |
France |
| Virani, Shafique (Roche 201406 Global Head of Neuroscience Partnering) |
Business Development Manager / Strategy Manager |
Roche (Group) |
Switzerland |
| Virchow, Sebastian |
n. a. |
Deutsche Bank (Group) |
Germany |
| Viribay, Miguel-Antonio (Sygnis 201504– VP Sales + Marketing before Thermo Fisher + Agilent + Life Technologies) |
Sales Manager / Marketing Manager |
Expedeon (Group) |
Germany |
| Virji, Sukaina (Suki) (Consilium 201706– joins London CSC office before 16y at Scrip/Informa) |
Public Relations Manager / Investor Relations Manager |
Consilium Strategic Communications Ltd. (CSC) |
United Kingdom (GB) |
| Vita, Giuseppe (Schering) |
n. a. |
Bayer (Group) |
Germany |
| Vitt, Daniel (Immunic 201701– CEO before 4SC 1997–201612 CSO + Co-Founder before Univ Würzburg) |
Chief Executive Officer (CEO) |
Immunic (Group) |
Germany |
| Vlachou, Angelika (bmp 201702 Investment Manager bmp) |
Investment Manager |
bmp (Group) |
Germany |
| Vlasak, Reinhard (Angewandte Biotechnologie GmbH 200810 CEO) |
Chief Executive Officer (CEO) |
Angewandte Biotechnologie GmbH (Applied BioTech – ABT) |
Austria |
| Vodopivec, Alexander (ViruSure 201211 Managing Director, Finance + Administration) |
Managing Director |
ViruSure GmbH |
Austria |
| Voegeli, Rainer (BioVisioN 200412 CBO) |
Chief Business Officer (CBO) |
Digilab (Group) |
Germany |
| Voelker-Albert, Moritz (EpiQMAx GmbH 201903 Managing Director + Co-Founder) |
Managing Director |
EpiQMAx GmbH |
Germany |
| Vogel, Bernard (Endeavour Vision 201409 Managing Partner + Co-founder) |
Managing Partner (investment firm) |
Endeavour Vision (Group) |
Switzerland |
| Vogel, Hanspeter (Bruker 201009 Director RI Research Instruments GmbH) |
n. a. |
Bruker Corporation (Group) |
Germany |
| Vogelmeier, Claus (Univ Gießen 201503 Professor of Internal + Respiratory Medicine) |
Professor |
University of Gießen (Justus Liebig University) |
Germany |
| Vogelstein, Bert (Johns Hopkins Univ 201704 Professor) |
Professor |
Johns Hopkins University |
United States (USA) |
| Vogeser, Gudrun (PIKA Weihenstephan GmbH 201308 Managing Director + Co-founder) |
Managing Director |
PIKA Weihenstephan GmbH |
Germany |
| Vogler, Raphael (ChemCon GmbH 201209 Managing Director) |
Managing Director |
ChemCon GmbH |
Germany |
| Voglmaier, Manfred (Definiens –200411–200810 VP BusDev Life Sciences) |
Business Development Manager / Strategy Manager |
AstraZeneca (Group) |
Germany |
| Vogt, Christian (BioHyTec 200503) |
n. a. |
BioHyTec (Verein für Bioanalytik und Biohybrid-Technologie e. V.) |
Germany |
| Vogt, Peter (Epigenomics 201601 Investor + Public Relations) |
Public Relations Manager / Investor Relations Manager |
Epigenomics (Group) |
Germany |
| Vogt, Reinhard (Sartorius 201308 Executive Board Member, Marketing, Sales, Services) |
Sales Manager / Marketing Manager |
Sartorius (Group) |
Germany |
| Voigt, Marc (Caprotec 201107– Managing Director + CFO + COO before Medical Enzymes AG before Revotar) |
Managing Director |
Caprotec Bioanalytics GmbH |
Germany |
| Voigt, Thor (Boehringer 1992–201903 CMO RETIRED 4/19) |
Chief Medical Officer (CMO) |
Boehringer Ingelheim (Group) |
Germany |
| Voigt, Tobias (Sachsen (govt) 201905 at Technologiegründerfonds Sachsen) |
n. a. |
Saxony (govt region) |
Germany |
| Volckmar, Klaus (LabWare 201003 Head German Office) |
President/Director/Head Business Group/Unit/Division |
LabWare (Group) |
Germany |
| Voliotis, Dimitris (CureVac 201901– CDO before Eisai Inc + 12years at Bayer HealthCare) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
CureVac (Group) |
United States (USA) |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 650x65px](/banner/iito-20181119-650-065-lse-life-sciences-europe-com.jpg)
1 2 3 ... 62 63 64 ... 68 69 70 
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px](/banner/iito-20181119-650-065-lsus-life-sciences-usa-com.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
